Nurix Therapeutics NRIX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 18.97 | 106.10 | -0.79 | -92,495 | -87 | |
| 2025Q3 | 9.24 | 106.23 | -0.83 | -83,095 | -78 | |
| 2025Q2 | 11.39 | 105.74 | -1.03 | -91,385 | -86 | |
| 2025Q1 | 11.88 | 113.16 | -0.52 | -48,322 | -43 | |
| 2024Q4 | 18.84 | 111.56 | -0.67 | -62,864 | -56 | |
| 2024Q3 | 22.47 | 110.45 | -0.75 | -64,657 | -59 | |
| 2024Q2 | 20.87 | 111.74 | -0.66 | -54,611 | -49 | |
| 2024Q1 | 14.70 | 109.19 | -0.71 | -48,540 | -45 | |
| 2023Q4 | 10.32 | 109.15 | -0.76 | -45,219 | -42 | |
| 2023Q3 | 7.86 | 108.05 | -0.77 | -45,334 | -42 | |
| 2023Q2 | 9.99 | 108.19 | -0.68 | -40,012 | -37 | |
| 2023Q1 | 8.88 | 110.25 | -0.45 | -26,765 | -24 | |
| 2022Q4 | 10.98 | 105.45 | -0.75 | -42,952 | -41 | |
| 2022Q3 | 13.03 | 104.22 | -0.86 | -48,690 | -47 | |
| 2022Q2 | 12.67 | 102.21 | -0.89 | -46,718 | -46 | |
| 2022Q1 | 14.01 | 100.69 | -1.01 | -45,715 | -45 | |
| 2021Q4 | 28.95 | 100.50 | -0.95 | -42,744 | -43 | |
| 2021Q3 | 29.96 | 100.78 | -0.85 | -37,953 | -38 | |
| 2021Q2 | 26.53 | 100.13 | -0.65 | -28,997 | -29 | |
| 2021Q1 | 31.09 | 100.65 | -0.60 | -26,414 | -26 |